ADHD Medication During Pregnancy and Breastfeeding
Women with ADHD have to make a difficult choice on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There are few data on how exposure to ADHD for a long time could affect the foetus.
medication for adults with add published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that further high-quality studies are needed.
Risk/Benefit Analysis
Women who are pregnant and take ADHD medication must consider the benefits of taking it versus the risks to the fetus. Doctors don't have enough data to provide clear recommendations however they can provide information on the risks and benefits to assist pregnant women to make an informed decision.
A study published in Molecular Psychiatry found that women who took ADHD medications during their early pregnancy did not have an higher risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a large population-based case-control study to determine the prevalence of major structural birth defects in babies born to mothers who had taken stimulants during early pregnancy, as well as those who had not. Clinical geneticists and pediatric cardiologists examined the cases to ensure correct case classification and to limit the possibility of bias.
The research conducted by the researchers was not without its limitations. Researchers were unable in the beginning, to separate the effects of the medication from the disorder. This limitation makes it difficult to determine whether the limited associations observed in the exposed groups are due to the use of medication or comorbidities that cause confusion. The researchers did not look at the long-term effects for the offspring.
The study did reveal that babies whose mothers had taken ADHD medication during pregnancy were at a slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or cut back on their medications prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not influenced by the stimulant medication that was used during pregnancy.
Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having to have an emergency caesarean section or having one whose baby scored low on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication taken during pregnancy.
The researchers suggest that the low risk associated with the use of ADHD medications during the early stages of pregnancy may be offset by the higher benefit to both the mother and child of continuing treatment for the woman's condition. Doctors should discuss with their patients about this and as much as possible, assist them improve coping skills which could reduce the effects of her disorder on her daily life and relationships.
Medication Interactions
Many doctors are faced with the decision of whether to continue treatment or stop during pregnancy as more women are diagnosed with ADHD. Most of the time, these decisions are made without solid and reliable evidence either way, so physicians have to weigh their experience, the experiences of other doctors, and what the research suggests on the subject as well as their best judgment for each patient.
The issue of potential risks to infants is extremely difficult. The research on this issue is based on observations rather than controlled studies and the results are contradictory. The majority of studies focus on live births, which may underestimate the severity of teratogenic effects that can lead to abortions or terminations of pregnancy. The study discussed in this journal club addresses these limitations by examining data on both live and deceased births.
Conclusion Some studies have shown a positive correlation between ADHD medications and certain birth defects However, other studies haven't shown such a relationship. Most studies show an unintended, or slight negative effect. In each case an in-depth evaluation of the potential risks and benefits is required.
For many women with ADHD who suffer from ADHD, the decision to stop medication is difficult if not impossible. In fact, in an article recently published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation, and family conflict for these patients. In addition, a decrease in medication can affect the ability to perform job-related tasks and drive safely, which are important aspects of a normal life for many people with ADHD.
She suggests that women who are not sure whether to take the medication or stop it due to their pregnancy educate family members, coworkers, and acquaintances about the condition, its effects on daily functioning, and the benefits of keeping the current treatment regimen. It will also help a woman feel confident about her decision. It is important to note that some drugs can pass through the placenta, so if the patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the medication could be passed on to the baby.
Birth Defects and Risk of
As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about the effects that the drugs might have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this subject. With two massive data sets, researchers were able to examine more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. Researchers discovered that, while the risk overall is low, first-trimester ADHD medication exposure was associated with slightly higher risk of specific heart defects like ventriculoseptal defects.
The authors of the study found no link between early medication use and congenital abnormalities such as facial clefting or club foot. The results are in the same vein as previous studies which showed an insignificant, but small increase in the number of cardiac malformations among women who began taking ADHD medication prior to the time of pregnancy. This risk increased during the latter stages of pregnancy, when a lot of women decided to stop taking their medication.
Women who took ADHD medication in the first trimester were more likely need a caesarean, have an insufficient Apgar after delivery, and have a baby who needed help breathing when they were born. However the authors of the study were unable to eliminate selection bias by limiting the study to women who did not have other medical issues that could have contributed to these findings.
The researchers hope that their research will help inform the clinical decisions of doctors who see pregnant women. The researchers suggest that, while discussing benefits and risks are important, the choice regarding whether or not to stop taking medication should be in light of the severity of each woman's ADHD symptoms and her needs.
The authors warn that, even though stopping the medication is an option to look into, it is not recommended because of the high incidence of depression and other mental problems in women who are expecting or have recently given birth. Additionally, the research suggests that women who decide to stop taking their medications are more likely to have difficulties getting used to life without them after the baby's arrival.
Nursing
The responsibilities of a new mom can be overwhelming. Women with ADHD who have to deal with their symptoms while attending doctor appointments and getting ready for the arrival of a child and adjusting to new household routines may face a lot of challenges. Many women decide to continue taking their ADHD medication during pregnancy.
The majority of stimulant drugs pass through breast milk in small quantities, so the risk for infant who is breastfeeding is low. The rate of exposure to medication will differ based on dosage, frequency of administration and the time of day. Additionally, different medications enter the baby’s system via the gastrointestinal tract or through breast milk. The effect on a newborn's health is not completely understood.
Due to the absence of research, some doctors may be inclined to discontinue stimulant drugs during a woman's pregnancy. It is a difficult decision for the mother, who must weigh the advantages of her medication against the potential risks to the foetus. As long as more information is available, doctors can inquire about pregnant patients if they have a history of ADHD or if they intend to take medication in the perinatal stage.
A increasing number of studies have proven that most women can safely continue taking their ADHD medication while they are pregnant and nursing. In response, an increasing number of patients are opting to do this. They have found, in consultation with their physicians, that the benefits of keeping their current medication outweigh any risk.
It is essential for women with ADHD who are considering breastfeeding to seek out a specialist psychiatrist's advice prior to becoming pregnant. They should discuss the medication they are taking with their physician, and the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also needed to help pregnant women with ADHD recognize the signs and the underlying disorder. They should also be informed about treatment options and strengthen coping mechanisms. This should be a multidisciplinary approach with the GPs, obstetricians, and psychiatry. Pregnancy counselling should include discussion of a management plan for both the mother as well as the child, and monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.